KDR and neoplasm: We established tumor xenografts from HEC-1-B and FGF2 overexpressing FGF2-B9 cell lines and treated FGF2-B9 xenograft-bearing mice with saline, [NSIS6S]-[NSIS]5 and sunitinib, an inhibitor of VEGFR2, PDGFR and FGFRs.